Clinical Trials Directory

Trials / Completed

CompletedNCT03520621

The Role of Sulfur Amino Acids in Risk of Kwashiorkor

Status
Completed
Phase
Study type
Observational
Enrollment
360 (actual)
Sponsor
Tufts University · Academic / Other
Sex
All
Age
36 Months – 59 Months
Healthy volunteers
Accepted

Summary

This observational cross-sectional study is investigating if young children in populations with higher prevalence of kwashiorkor malnutrition have lower dietary sulfur amino acid intake than populations with lower prevalence of kwashiorkor, controlling for multiple potential confounding factors. Intake is estimated through diet recalls during interviews with a child's caregiver, analysis of urine samples and analysis of food samples for their amino acid profiles.

Detailed description

Kwashiorkor is one of two categorizations of severe acute malnutrition, but its etiology remains unclear. Although kwashiorkor is found only where diets are low in quality protein, comparisons of total dietary protein of individual children with and without kwashiorkor has been inconclusive. This study aims to compare amino acid profiles of the diets, not just total protein. Evidence has shown that children with kwashiorkor consistently have very low circulating levels of sulfur amino acids (cysteine and methionine). Typical staple foods in regions with endemic kwashiorkor are generally poor in sulfur amino acids and the signs characterizing kwashiorkor can plausibly be explained by a shortage of sulfur amino acids. In eastern Democratic Republic of the Congo, certain populations have chronically higher prevalence of kwashiorkor than neighboring populations with similar livelihoods, religion, environment, language and ethnicity. This study will compare these two populations to understand what differences between them may explain the difference in prevalence.

Conditions

Interventions

TypeNameDescription
OTHERNo interventionno intervention

Timeline

Start date
2016-06-01
Primary completion
2016-08-14
Completion
2017-08-02
First posted
2018-05-11
Last updated
2018-05-11

Locations

1 site across 1 country: Democratic Republic of the Congo

Source: ClinicalTrials.gov record NCT03520621. Inclusion in this directory is not an endorsement.